Glasgow Memory Clinic conducts several different clinical trials including Early Trial, Engage and Daybreak. We are now pleased to offer the MissionAD clinical research programme.
The MissionAD study is a clinical research programme that examines the effects of an investigational drug for the early stages of Alzheimer’s disease. Doctors are studying this investigational drug to see if it is safe for patients and if successful it will help people with Alzheimer’s in the future.
People who qualify for this research study may receive:
- Investigational drug
- Study-related care from a local study doctor
- Reimbursement for travel expenses
To qualify for this study, you must:
- Be 50 to 85 years of age
- Be experiencing noticeable changes in memory or thinking
- Have a regular study partner available
- Doctors may also check other requirements to confirm that you qualify for this study.
Why is clinical research into Alzheimer’s disease so important?
A clinical research study is a research project done with human volunteers to learn more about new investigational drugs and treatments. Some volunteers are interested in access to investigational drugs or treatments, while others volunteer to help advance science. Whatever your reason for participating, you are contributing to helping us find a cure for Alzheimer’s disease.
You can find out more about participating in a clinical trial at the Glasgow Memory Clinic here.
Please contact us if you would like more information or if you are considering taking part in a clinical study.